136 related articles for article (PubMed ID: 25720362)
1. The importance of echocardiography and an individual approach to patent ductus arteriosus treatment in extremely preterm infants.
Gudmundsdottir A; Johansson S; Håkansson S; Norman M; Källen K; Bonamy AK
Neonatology; 2015; 107(4):257. PubMed ID: 25720362
[No Abstract] [Full Text] [Related]
2. Future Benefits of Sequential Echocardiography: Unmasking the Indications for Treatment of Patent Ductus Arteriosus in Extremely Preterm Infants.
Olsson KW; Sindelar R
Neonatology; 2015; 108(2):99. PubMed ID: 26068311
[No Abstract] [Full Text] [Related]
3. Adequate timely treatment of patent ductus arteriosus in extremely low birth weight infants: an ongoing challenge.
Meyer S
Neonatology; 2015; 107(4):256. PubMed ID: 25721918
[No Abstract] [Full Text] [Related]
4. Timing of pharmacological treatment for patent ductus arteriosus and risk of secondary surgery, death or bronchopulmonary dysplasia: a population-based cohort study of extremely preterm infants.
Gudmundsdottir A; Johansson S; Håkansson S; Norman M; Källen K; Bonamy AK
Neonatology; 2015; 107(2):87-92. PubMed ID: 25412681
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Therapeutic Response to Cyclooxygenase Inhibitors in Preterm Infants with Patent Ductus Arteriosus.
Hu Y; Jin H; Jiang Y; Du J
Pediatr Cardiol; 2018 Apr; 39(4):647-652. PubMed ID: 29468349
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes.
Liebowitz M; Clyman RI
J Pediatr; 2017 Aug; 187():119-126.e1. PubMed ID: 28396025
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of ibuprofen versus indomethacin for the treatment of patent ductus arteriosus in the preterm infant: reviewing the evidence.
Donze A; Smith JR; Bryowsky K
Neonatal Netw; 2007; 26(3):187-95. PubMed ID: 17521065
[No Abstract] [Full Text] [Related]
8. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
[TBL] [Abstract][Full Text] [Related]
9. [Ibuprofen--a new application for pharmacological closure of patent ductus arteriosus in preterm infants. Preliminary report].
Adamska E
Med Wieku Rozwoj; 2000; 4(2 Suppl 3):65-71. PubMed ID: 11328971
[TBL] [Abstract][Full Text] [Related]
10. Ibuprofen and patent ductus arteriosus.
Clyman RI
N Engl J Med; 2000 Sep; 343(10):728-30. PubMed ID: 10974138
[No Abstract] [Full Text] [Related]
11. Indomethacin-Responsive Patent Ductus Arteriosus in an Extremely Preterm Infant at 8 Weeks Postnatal Age.
Chhina AS; Sharma BK; Raja M; Singhal M; Shenoi A
Indian J Pediatr; 2015 Jul; 82(7):655-6. PubMed ID: 25640067
[No Abstract] [Full Text] [Related]
12. Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants.
ElHassan NO; Bird TM; King AJ; Ambadwar PB; Jaquiss RD; Kaiser JR; Robbins JM
J Neonatal Perinatal Med; 2014 Jan; 7(3):229-35. PubMed ID: 25322995
[TBL] [Abstract][Full Text] [Related]
13. Treatment of patent ductus arteriosus: indomethacin or ibuprofen?
Linder N; Bello R; Hernandez A; Rosen C; Birk E; Sirota L; Pushkov Y; Klinger G
Am J Perinatol; 2010 May; 27(5):399-404. PubMed ID: 20013578
[TBL] [Abstract][Full Text] [Related]
14. Comparison of oral ibuprofen and indomethacin on closure of patent ductus arteriosus in preterm infants.
Pourarian Sh; Pishva N; Madani A; Rastegari M
East Mediterr Health J; 2008; 14(2):360-5. PubMed ID: 18561728
[TBL] [Abstract][Full Text] [Related]
15. Ibuprofen versus indomethacin treatment of patent ductus arteriosus: comparative effectiveness and complications.
Chan NM; Law CW; Kwan KF
Hong Kong Med J; 2014 Jun; 20(3):205-12. PubMed ID: 24493687
[TBL] [Abstract][Full Text] [Related]
16. Patent ductus arteriosus in preterm infants born before 30 weeks' gestation: high rate of spontaneous closure after hospital discharge.
Romagnoli V; Pedini A; Santoni M; Scutti G; Colaneri M; Pozzi M; Cogo PE; Carnielli VP
Cardiol Young; 2018 Aug; 28(8):995-1000. PubMed ID: 29954463
[TBL] [Abstract][Full Text] [Related]
17. Patent Ductus Arteriosus and Short- and Long-Term Respiratory Outcomes.
Bancalari E
Am J Perinatol; 2016 Sep; 33(11):1055-7. PubMed ID: 27603534
[TBL] [Abstract][Full Text] [Related]
18. Platelets and ductus arteriosus closure in neonates.
Sallmon H; Delaney CA
Semin Perinatol; 2023 Mar; 47(2):151719. PubMed ID: 36925318
[TBL] [Abstract][Full Text] [Related]
19. [Patent ductus arteriosus in premature infants].
Bratlid D; Farstad T
Tidsskr Nor Laegeforen; 2009 Aug; 129(15):1455-8. PubMed ID: 19690594
[TBL] [Abstract][Full Text] [Related]
20. Neurodevelopmental outcome after COX inhibitor treatment for patent ductus arteriosus.
Rheinlaender C; Helfenstein D; Pees C; Walch E; Czernik C; Obladen M; Koehne P
Early Hum Dev; 2010 Feb; 86(2):87-92. PubMed ID: 20153127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
